ZNF417 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.16789999951672E-07 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.479360E-03 |
Normal-vs-Stage2 |
3.181200E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
3.793700E-02 |
Stage1-vs-Stage2 |
5.992600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
4.711000E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
7.637800E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.72987000000013E-05 |
Normal-vs-AfricanAmerican |
1.565210E-01 |
Normal-vs-Asian |
3.303600E-02 |
Caucasian-vs-AfricanAmerican |
4.414000E-02 |
Caucasian-vs-Asian |
5.710000E-01 |
AfricanAmerican-vs-Asian |
1.200160E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.416360E-03 |
Normal-vs-Female |
1.405310E-04 |
Male-vs-Female |
7.118200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.523600E-02 |
Normal-vs-Extreme_Weight |
2.163600E-04 |
Normal-vs-Obese |
9.017600E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.854400E-01 |
Normal_Weight-vs-Obese |
6.190000E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.146190E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.833400E-01 |
Normal-vs-Age(41-60Yrs) |
3.485700E-02 |
Normal-vs-Age(61-80Yrs) |
2.18009999999325E-05 |
Normal-vs-Age(81-100Yrs) |
1.404230E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.018780E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.319900E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.126000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.347600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.423800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.596200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.711400E-01 |
Normal-vs-Grade 3 |
4.698000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
6.467400E-01 |
Grade 2-vs-Grade 4 |
9.711400E-01 |
Grade 3-vs-Grade 4 |
4.698000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.94150000000426E-05 |
Normal-vs-N1 |
1.792160E-02 |
N0-vs-N1 |
7.355700E-02 |
|
|